These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2898813)

  • 21. A comparative study of the effects of prostaglandins and H2-receptor antagonists on gastric acid secretion, mucosal blood flow and ulcer formation.
    Banerjee AK; Christmas AJ; Hall CE
    Arzneimittelforschung; 1979; 29(4):634-9. PubMed ID: 39581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
    Garnett WR
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New aspects of the neural regulation of gastric acid secretion].
    Eysselein VE
    Z Gastroenterol Verh; 1987 Apr; 22():91-6. PubMed ID: 2442917
    [No Abstract]   [Full Text] [Related]  

  • 24. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
    Nakano M; Kitano S; Nanri M; Kiniwa M
    Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of acid-suppressive agents in patients with gastroesophageal reflux disease.
    Schentag JJ; Goss TF
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S7-10. PubMed ID: 8097364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of different histamine H2-receptor antagonists on the gastric acid secretion of the isolated whole stomach of the mouse and on the heart rate of spontaneously beating atrium of the guinea-pig.
    Szelenyi I; Postius S
    Arzneimittelforschung; 1984; 34(7):787-8. PubMed ID: 6149753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of gastric acid secretion by H2-receptor antagonists.
    Nielsen ST
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):151-60. PubMed ID: 2876686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

  • 30. Antisecretory effects of two new histamine H2-receptor antagonists.
    Bickel M; Herling AW; Rising TJ; Wirth K
    Arzneimittelforschung; 1986 Sep; 36(9):1358-63. PubMed ID: 2878669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.
    Lambers CB; Lind T; Moberg S; Jansen JB; Olbe L
    N Engl J Med; 1984 Mar; 310(12):758-61. PubMed ID: 6142418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of histamine H2-receptor antagonists on blood flow and secretion of the resting and stimulated stomach.
    Varró V; Döbrönte Z; Sági I
    Mater Med Pol; 1981; 13(1):3-6. PubMed ID: 6119401
    [No Abstract]   [Full Text] [Related]  

  • 33. Genotoxicity studies of gastric acid inhibiting drugs.
    Burlinson B; Morriss SH; Gatehouse DG; Tweats DJ
    Lancet; 1990 Feb; 335(8686):419-20. PubMed ID: 1968153
    [No Abstract]   [Full Text] [Related]  

  • 34. Neurochemical control of oxyntic cell secretion.
    Black JW
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():31-5. PubMed ID: 1976585
    [No Abstract]   [Full Text] [Related]  

  • 35. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
    Leite LP; Just RJ; Castell DO; Lagerström PO
    Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omeprazole: a new approach to gastric acid suppression.
    Buhl K; Clearfield HR
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nocturnal gastric acid breakthrough may not be a problem of acid secretion only.
    Hongo M
    J Gastroenterol; 2003; 38(9):915-7. PubMed ID: 14564642
    [No Abstract]   [Full Text] [Related]  

  • 38. H2-receptor antagonist nonresponders and omeprazole.
    Walker S; Treiber G; Sarem-Aslani A; Klotz U
    Dig Dis Sci; 1992 Aug; 37(8):1302. PubMed ID: 1354154
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of gastric acid secretion in the gastric brooding frog, Rheobatrachus silus.
    Tyler MJ; Shearman DJ; Franco R; O'Brien P; Seamark RF; Kelly R
    Science; 1983 May; 220(4597):609-10. PubMed ID: 6573024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological control of gastric acid secretion.
    Jack D
    S Afr Med J; 1988 Jul; 74 Suppl():8-10. PubMed ID: 2898813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.